GenSci122
/ GeneScience
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 23, 2025
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=163 | Recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
January 13, 2025
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=163 | Not yet recruiting | Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1